Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ERX Pharmaceuticals Logo
ERX Pharmaceuticals Growth Score
91
CB Rank
102494
Heat Score
67
ERX Pharmaceuticals Inc. focuses on a recent knowledge of science of obesity.
Founded
obfuscation
PrivateFunding Round Cambridge, Massachusetts, United States1-10 www.erxpharmaceuticals.com/
Overview

ERX Pharmaceuticals
Total Funding
obfuscation
Growth Score
91
Heat Score
67

Total Funding
obfuscation
obfuscation
Funding Round raised
obfuscation
Growth Score91
-2 pts
in past quarter
Heat Score 67
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ERX Pharmaceuticals

CB Rank
102494
ERX Pharmaceuticals Inc. focuses on a recent knowledge of science of obesity.
Founded
obfuscation
PrivateFunding Round Cambridge, Massachusetts, United States1-10 www.erxpharmaceuticals.com/

Funding Rounds

Funding Round
OBF
in
obfuscation

Key People

Details

Legal Name ERX Pharmaceuticals
Operating Status Active
Company Type For Profit
About the Company
ERX Pharmaceuticals Inc. is creating first-in-class leptin additives for the cure of obesity and other illnesses focuses on a recent knowledge of science of obesity.
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ERX-1000
ERX-1000 is a leptin sensitizer drug candidate designed to improve leptin sensitivity for the treatment of obesity.
Next Generation Leptin Sensitizer Candidates
These are novel analogs of ERX-1000 being developed as orally active leptin sensitizers for obesity and related metabolic diseases.

Research & Development

ERX Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round
obfuscation
Funding Round - ERX Pharmaceuticals Logo
Funding Round - ERX Pharmaceuticals
—
obfuscation
— Funding Round

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 1 Contacts 1

Employee Profiles

News

News and Press

News•Jul 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 15, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

60
-50.41%
 in past month

IT Spend

$36.8KThis year, ERX Pharmaceuticals is projected to spend $36.8K on IT, according to Aberdeen.

Active Website Tech Count

26ERX Pharmaceuticals is actively using 26 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.

Total IP

5The intellectual property of ERX Pharmaceuticals includes 5 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ERX Pharmaceuticals's headquarters? ERX Pharmaceuticals is located in Cambridge, Massachusetts, United States.When was the last funding round for ERX Pharmaceuticals? ERX Pharmaceuticals closed its last funding round on
obfuscation
from a Undisclosed round.Who are ERX Pharmaceuticals's competitors? Alternatives and possible competitors to ERX Pharmaceuticals may include Kailera Therapeutics, BioAge Labs, and  Aardvark Therapeutics.How much funding has ERX Pharmaceuticals raised to date? ERX Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|